Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01583296 · ClinicalTrials.gov registry record · NA

LUCHAR - Latinos Using Counseling for Help With Asthma and Anxiety Reduction

A NA study, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT01583296 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 53 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01583296, a NA study, has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

The research plan involves two aims: 1) Cultural adaptation of the Panic-Asthma Treatment and 2) a randomized, placebo-controlled pilot study. Participants will be primarily recruited from two major, inner-city hospitals in the Bronx, NY. Diagnosis of Panic Disorder (PD) will be based on the Structured Clinical Interview for DSM-IV. Diagnosis of asthma will be based on national guidelines. The first year of the project will be devoted to approximately 5 focus groups with Latino (primarily Puerto Rican) participants, pilot treatment and participant feedback. The protocol will be adapted based on key cultural issues that are systematically observed during Phase 1. During Years 2-3, 40 participants with PD and asthma will be randomized into two treatment arms: Panic-Asthma Treatment and an active placebo condition involving music therapy and paced breathing at resting respiration rates. Each treatment will involve 8 weekly sessions. An interviewer, who will be blind to treatment condition, will conduct assessments at pre-treatment, mid-treatment, post-treatment, and 3-month follow-up. The primary hypotheses are that participants in the Panic-Asthma treatment group will have greater decreases than subjects in the placebo condition on the PD severity scale and albuterol use (i.e., rescue asthma medication) from pre-test to post-test and across 3-month follow-up.

Interventions

  • BEHAVIORAL Music Relaxation Therapy (MRT)
  • BEHAVIORAL CBT and HRVB

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2010-07
Est. Completion 2013-12
Phase NA

Sponsor

Albert Einstein College of Medicine

175 total trials

What the Registry Record Tells You About NCT01583296

The ClinicalTrials.gov registry entry for NCT01583296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Music Relaxation Therapy (MRT) is the first listed.

NCT01583296 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01583296 about?

NCT01583296 is a clinical study titled "LUCHAR - Latinos Using Counseling for Help With Asthma and Anxiety Reduction". The research plan involves two aims: 1) Cultural adaptation of the Panic-Asthma Treatment and 2) a randomized, placebo-controlled pilot study. Participants will be primarily recruited from two major, inner-city hospitals in the Bronx, NY. Diagnosis of Panic Disorder (PD) will be based on the Structu...

What is the current status of trial NCT01583296?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2010-07. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01583296?

The interventions under investigation include: Music Relaxation Therapy (MRT) (BEHAVIORAL), CBT and HRVB (BEHAVIORAL).

Who is sponsoring clinical trial NCT01583296?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.